Evolution of Lipid Metabolism in the Injured Mouse Spinal Cord
- 17 February 2025
- journal article
- research article
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 42 (3-4) , 182-196
Abstract
Following spinal cord injury (SCI), there is a short-lived recovery phase that ultimately plateaus. Understanding changes within the spinal cord over time may facilitate targeted approaches to prevent and/or reverse this plateau and allow for continued recovery. Untargeted metabolomics revealed distinct metabolic profiles within the injured cord during recovery (7 days postinjury [DPI]) and plateau (21 DPI) periods in a mouse model of severe contusion SCI. Alterations in lipid metabolites, particularly those involved in phospholipid (PL) metabolism, largely contributed to overall differences. PLs are hydrolyzed by phospholipases A2 (PLA2s), yielding lysophospholipids (LPLs) and fatty acids (FAs). PL metabolites decreased between 7 and 21 DPI, whereas LPLs increased at 21 DPI, suggesting amplified PL metabolism during the plateau phase. Expression of various PLA2s also differed between the two time points, further supporting dysregulation of PL metabolism during the two phases of injury. FAs, which can promote inflammation, mitochondrial dysfunction, and neuronal damage, were increased regardless of time point. Carnitine can bind with FAs to form acylcarnitines, lessening FA-induced toxicity. In contrast to FAs, carnitine and acylcarnitines were increased at 7 DPI, but decreased at 21 DPI, suggesting a loss of carnitine-mediated mitigation of FA toxicity at the later time point, which may contribute to the cessation of recovery post-SCI. Alterations in oxidative phosphorylation and tricarboxylic acid cycle metabolites were also observed, indicating persistent although dissimilar disruptions in mitochondrial function. These data aid in increasing our understanding of lipid metabolism following SCI and have the potential to lead to new biomarkers and/or therapeutic strategies.Keywords
This publication has 51 references indexed in Scilit:
- Metabolomics profiling reveals distinct, sex‐specific signatures in serum and brain metabolomes in mouse models of Alzheimer's diseaseAlzheimer's & Dementia, 2024
- Parallel Metabolomic Profiling of Cerebrospinal Fluid, Plasma, and Spinal Cord to Identify Biomarkers for Spinal Cord InjuryJournal of Molecular Neuroscience, 2021
- Roles of inflammation, neurogenic inflammation, and neuroinflammation in painJournal of Anesthesia, 2018
- Neurorestorative Targets of Dietary Long-Chain Omega-3 Fatty Acids in Neurological InjuryMolecular Neurobiology, 2014
- Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injuryAnnals of Neurology, 2014
- Fatty Acid Oxidation2013
- Acetyl-l-carnitine suppresses apoptosis of thioredoxin 2-deficient DT40 cellsArchives of Biochemistry and Biophysics, 2008
- A novel role of phospholipase A2 in mediating spinal cord secondary injuryAnnals of Neurology, 2006
- L‐carnitine inhibits hepatocarcinogenesis via protection of mitochondriaInternational Journal of Cancer, 2004
- cPLA2 is phosphorylated and activated by MAP kinaseCell, 1993